candesartan has been researched along with bendroflumethiazide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Almuntaser, I; Brown, A; Crean, P; Feely, J; King, G; Mahmud, A; Murphy, R | 1 |
1 review(s) available for candesartan and bendroflumethiazide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for candesartan and bendroflumethiazide
| Article | Year |
|---|---|
Blood pressure control determines improvement in diastolic dysfunction in early hypertension.
Topics: Antihypertensive Agents; Bendroflumethiazide; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Female; Heart Ventricles; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Regression Analysis; Tetrazoles; Ultrasonography; Ventricular Dysfunction, Left | 2009 |